Concepedia

Christopher O’Brien

CO

27

Publications

2K

Citations

22

H-Index

1991

Active since

Affiliations

Colorado Neurological Institute(Current)

Neurocrine Biosciences (United States)

Hofstra University

Wayne State University

Albany Medical Center Hospital

Christopher O’Brien is an author at Colorado Neurological Institute specializing in medicine, rehabilitation, and physical therapy.

Top concepts

Publications per year

1991–2025

27

Publications

27

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

Robert A. Hauser, Stewart A. Factor, Stephen R. Marder et al. · American Journal of Psychiatry · 2017 · 386 citations · Full text

A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

Robert A. Hauser, Jeffrey Friedlander, Theresa Zesiewicz et al. · Clinical Neuropharmacology · 2000 · 290 citations

, , +15

The natural history of embouchure dystonia

Steven J. Frucht, Stanley Fahn, Paul Greene et al. · Movement Disorders · 2001 · 170 citations

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

Christopher O’Brien, Roland Jimenez, Robert A. Hauser et al. · Movement Disorders · 2015 · 125 citations · Full text

Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience

Richard Trosch, Joseph H. Friedman, M. C. Lannon et al. · Movement Disorders · 1998 · 124 citations

Rows per page

1–5 of 27